跳至主要内容
临床试验/NCT04143932
NCT04143932招募中不适用

Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study

Turkish Hematology Association1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Overall Survival

研究概览

简要总结

This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey

详细描述

In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end.

All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed as multiple myeloma
  • Patients signed informed consent form
  • Patients received no more then 2 lines of therapy

排除标准

  • Patients below 18 years old

结局指标

主要结局

Overall Survival

时间窗: [Time Frame: 5 Years]

Time from the diagnosis to the death

Progression Free Survival

时间窗: [Time Frame: 5 Years]

Time from the initiation of treatment to the death from any cause or progression

次要结局

未报告次要终点

研究者

发起方
Turkish Hematology Association
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验